CLINICAL_TRIALS
trial_result
· 2018-08-09
Clinical Trial Update: Aggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial) [Phase 3]
Summary
Phase 3 trial update on aggressive cholesterol therapy to reduce vein graft events after CABG; study completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Boca Raton Regional Hospital | Conditions: Saphenous Vein Graft Disease | Phase 3 | Status: COMPLETED | Results posted: 2018-08-09